Avalo Therapeutics, Inc.·4

Jun 18, 4:44 PM ET

Truex Samantha 4

4 · Avalo Therapeutics, Inc. · Filed Jun 18, 2025

Insider Transaction Report

Form 4
Period: 2025-06-17
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-17+20,10020,100 total
    Exercise: $4.47Exp: 2035-06-17Common Stock (20,100 underlying)
Footnotes (1)
  • [F1]The stock option vests 100% on the first anniversary of the date of grant, subject to the Eligible Director's continued service on such vesting date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT